By shedding light on these mechanisms, our research aims to unravel the involvement of ALDH2 in the complex interplay between obesity, oxidative stress, and AF, providing valuable insights into potential therapeutic targets. This evidence concerns the gene ALDH2 and atrial fibrillation.